At a glance
ClinicalIndex Comparison RecordN/ACompleted· 263 enrolled
Drug / intervention
Heart transplantprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational Study of Alloimmunity in Cardiac Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Apr 27, 2007·Updated Jan 1, 2016
In Brief
An observational study evaluating Heart transplant for Heart Transplant. Completed, enrolled 263 participants across 12 sites.
Detailed Summary
Injury of transplant tissue by a transplant recipient's immune system continues to be the leading cause of graft rejection and recipient death. The purpose of this study is to identify a single test or a combination of noninvasive tests currently used for heart transplant monitoring that correlate to long-term graft survival.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Transplant
CountriesUnited States
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 2007
Enrollment StartJun 2007
Primary CompletionJul 2011
TodayJul 2026
First PostedApr 27, 2007
Enrollment StartJun 1, 2007
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 19.2 years ago
Interventions
Heart transplantprocedure
People in this study will have a heart transplant and be monitored for signs of rejection